[HTML][HTML] BH3-mimetic drugs: blazing the trail for new cancer medicines
Defects in apoptotic cell death can promote cancer and impair responses of malignant cells
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.
D Merino, GL Kelly, G Lessene, AH Wei, AW Roberts… - Cancer Cell, 2018 - europepmc.org
Defects in apoptotic cell death can promote cancer and impair responses of malignant cells
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.
D Merino, GL Kelly, G Lessene, AH Wei, AW Roberts… - 2018 - ahro.austin.org.au
Defects in apoptotic cell death can promote cancer and impair responses of malignant cells
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
D Merino, GL Kelly, G Lessene, AH Wei… - Cancer …, 2018 - research.monash.edu
Defects in apoptotic cell death can promote cancer and impair responses of malignant cells
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
[HTML][HTML] BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
D Merino, GL Kelly, G Lessene, AH Wei, AW Roberts… - Cancer Cell, 2018 - Elsevier
Defects in apoptotic cell death can promote cancer and impair responses of malignant cells
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
[引用][C] BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
D Merino, GL Kelly, G Lessene, AH Wei, AW Roberts… - Cancer Cell, 2018 - cir.nii.ac.jp
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
[PDF][PDF] BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
A Strasser - Cancer Cell, 2018 - researchmgt.monash.edu
Defects in apoptotic cell death can promote cancer and impair responses of malignant cells
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
D Merino, GL Kelly, G Lessene, AH Wei… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Defects in apoptotic cell death can promote cancer and impair responses of malignant cells
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
D Merino, GL Kelly, G Lessene, AH Wei… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Defects in apoptotic cell death can promote cancer and impair responses of malignant cells
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell …